Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
450 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00338247 | EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer | approved for marketing | — | — | NovartisINDUSTRY | 45 | Apr 6, 2016 | clinicaltrials |
| NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 627 | Hoffmann-La RocheINDUSTRY | 20 | Apr 1, 2016 | clinicaltrials |
| NCT01151410 |
| An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age |
| completed |
| Phase 3 |
| 208 |
| Novartis PharmaceuticalsINDUSTRY |
| 7 |
| Mar 7, 2016 |
| clinicaltrials |
| NCT00479752 | Safety and Efficacy of Folfox4 + Weekly Cetuximab vs Folfox 4+Biweekly Cetuximab by Metastatic Colorectal Cancer(CORE 2) | completed | Phase 2 | 151 | Central European Cooperative Oncology GroupOTHER | 13 | Feb 18, 2016 | clinicaltrials |
| NCT02523638 | Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients(PEN-PV) | completed | Phase 3 | 30 | AOP Orphan Pharmaceuticals AGINDUSTRY | 8 | Feb 17, 2016 | clinicaltrials |
| NCT01250379 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA) | completed | Phase 3 | 494 | Hoffmann-La RocheINDUSTRY | 13 | Feb 11, 2016 | clinicaltrials |
| NCT01697072 | First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma(RILOMET-1) | terminated | Phase 3 | 609 | AmgenINDUSTRY | 27 | Feb 9, 2016 | clinicaltrials |
| NCT00334282 | Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma | completed | Phase 3 | 435 | GlaxoSmithKlineINDUSTRY | 25 | Feb 5, 2016 | clinicaltrials |
| NCT01466231 | Everolimus in Refractory Testicular Germ Cell Cancer | completed | Phase 2 | 15 | National Cancer Institute, SlovakiaOTHER_GOV | 1 | Jan 12, 2016 | clinicaltrials |
| NCT00412776 | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer | terminated | Phase 2 / Phase 3 | 165 | Sesen Bio, Inc.INDUSTRY | 18 | Dec 23, 2015 | clinicaltrials |
| NCT01360840 | EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer(PERSEUS) | completed | Phase 2 | 180 | EMD SeronoINDUSTRY | 12 | Dec 14, 2015 | clinicaltrials |
| NCT01223027 | Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma | completed | Phase 3 | 564 | Novartis PharmaceuticalsINDUSTRY | 27 | Dec 7, 2015 | clinicaltrials |
| NCT00409188 | Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)(START) | completed | Phase 3 | 1,513 | EMD SeronoINDUSTRY | 33 | Nov 20, 2015 | clinicaltrials |
| NCT01234311 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | completed | Phase 3 | 1,245 | Active Biotech ABINDUSTRY | 37 | Oct 21, 2015 | clinicaltrials |
| NCT00391066 | Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)(LUCID) | terminated | Phase 2 | 627 | BiogenINDUSTRY | 23 | Oct 2, 2015 | clinicaltrials |
| NCT00293124 | Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors | completed | Phase 3 | 125 | Central European Cooperative Oncology GroupOTHER | 10 | Aug 13, 2015 | clinicaltrials |
| NCT01121406 | BI 6727 (Volasertib) Randomised Trial in Ovarian Cancer | completed | Phase 2 | 110 | Boehringer IngelheimINDUSTRY | 5 | Aug 13, 2015 | clinicaltrials |
| NCT00510068 | Efficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine Tumors(RADIANT-3) | completed | Phase 3 | 410 | Novartis PharmaceuticalsINDUSTRY | 18 | Jul 1, 2015 | clinicaltrials |
| NCT01423500 | ALL-SCT BFM International- HSCT in Children and Adolescents With ALL(ALL-SCT-BFMi) | unknown | Phase 3 | 405 | St. Anna KinderkrebsforschungOTHER | 11 | Jun 26, 2015 | clinicaltrials |
| NCT01309841 | Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation | completed | Phase 3 | 652 | AstraZenecaINDUSTRY | 4 | Jun 1, 2015 | clinicaltrials |
| NCT01384292 | Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain | terminated | Phase 3 | 14 | AstraZenecaINDUSTRY | 14 | Jun 1, 2015 | clinicaltrials |
| NCT00448591 | A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. | completed | Phase 3 | 2,296 | Hoffmann-La RocheINDUSTRY | 36 | May 25, 2015 | clinicaltrials |
| NCT00075270 | Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer | completed | Phase 3 | 580 | GlaxoSmithKlineINDUSTRY | 25 | May 6, 2015 | clinicaltrials |
| NCT01519700 | Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim(PIONEER) | completed | Phase 3 | 218 | SandozINDUSTRY | 6 | May 6, 2015 | clinicaltrials |
| NCT00254904 | Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC | terminated | Phase 3 | 839 | PfizerINDUSTRY | 24 | Mar 30, 2015 | clinicaltrials |
| NCT00457691 | Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 768 | PfizerINDUSTRY | 34 | Mar 30, 2015 | clinicaltrials |
| NCT00556322 | A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 27 | Feb 23, 2015 | clinicaltrials |
| NCT00556712 | A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 889 | Hoffmann-La RocheINDUSTRY | 28 | Feb 11, 2015 | clinicaltrials |
| NCT01254279 | Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen | completed | Phase 3 | 984 | SanofiINDUSTRY | 29 | Jan 21, 2015 | clinicaltrials |
| NCT00412061 | Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor(RADIANT-2) | completed | Phase 3 | 429 | Novartis PharmaceuticalsINDUSTRY | 15 | Nov 21, 2014 | clinicaltrials |
| NCT01650805 | Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC) | terminated | Phase 3 | 307 | Ariad PharmaceuticalsINDUSTRY | 24 | Nov 17, 2014 | clinicaltrials |
| NCT00061984 | Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma | completed | Phase 3 | 455 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Oct 27, 2014 | clinicaltrials |
| NCT00374322 | Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer | completed | Phase 3 | 3,166 | GlaxoSmithKlineINDUSTRY | 33 | Aug 18, 2014 | clinicaltrials |
| NCT00002641 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT01189253 | Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma | terminated | Phase 2 / Phase 3 | 133 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00925548 | STRIDE - STimulating Immune Response In aDvanced brEast Cancer(STRIDE) | terminated | Phase 3 | 16 | EMD SeronoINDUSTRY | 12 | Jul 24, 2014 | clinicaltrials |
| NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | completed | Phase 3 | 442 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 17 | Jul 23, 2014 | clinicaltrials |
| NCT00424255 | Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery | completed | Phase 3 | 688 | GlaxoSmithKlineINDUSTRY | 22 | Jul 18, 2014 | clinicaltrials |
| NCT00148798 | Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)(FLEX) | completed | Phase 3 | 1,861 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 28 | Jun 25, 2014 | clinicaltrials |
| NCT00378690 | A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD(ICELAND) | completed | Phase 3 | 706 | Astellas Pharma IncINDUSTRY | 10 | Jun 4, 2014 | clinicaltrials |
| NCT00038467 | Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer(IES) | completed | Phase 3 | 4,740 | PfizerINDUSTRY | 37 | May 7, 2014 | clinicaltrials |
| NCT00989131 | Study of Paclitaxel in Patients With Ovarian Cancer | completed | Phase 3 | 789 | Oasmia Pharmaceutical ABINDUSTRY | 16 | Feb 4, 2014 | clinicaltrials |
| NCT01410955 | Prevention of Irinotecan Induced Diarrhea by Probiotics | completed | Phase 3 | 46 | Monsea Ltd.INDUSTRY | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | completed | Phase 3 | 472 | GlaxoSmithKlineINDUSTRY | 6 | Jan 20, 2014 | clinicaltrials |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | completed | Phase 3 | 80 | GlaxoSmithKlineINDUSTRY | 20 | Jan 14, 2014 | clinicaltrials |
| NCT00596830 | Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology | terminated | Phase 3 | 681 | PfizerINDUSTRY | 26 | Jan 13, 2014 | clinicaltrials |
| NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | completed | Phase 3 | 670 | Medical Research CouncilOTHER_GOV | 4 | Dec 19, 2013 | clinicaltrials |
| NCT00721123 | A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid Arthritis | completed | Phase 3 | 538 | Hoffmann-La RocheINDUSTRY | 17 | Nov 28, 2013 | clinicaltrials |
| NCT00514917 | A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)(Rising PSA) | terminated | Phase 3 | 413 | SanofiINDUSTRY | 9 | Nov 4, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials